logo

Celldex Therapeutics Inc. (CLDX)



Trade CLDX now with
  Date
  Headline
11/9/2018 8:02:47 AM Celldex Presents Promising Interim Data From Phase 1 Study Of Differentiated CD40 Agonist CDX-1140
11/7/2018 4:11:03 PM Celldex Therapeutics Q3 Loss/share $0.04 Vs. Loss $0.20 Year Ago
8/8/2018 4:03:58 PM Celldex Therapeutics Q2 Loss/share $0.11 Vs. Loss $0.23 Year Ago
5/10/2018 8:04:17 AM Celldex Therapeutics Q1 Loss Per Share $0.84 Vs Loss $0.28 Last Year
4/16/2018 7:01:36 AM Celldex Says METRIC Study In Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
3/7/2018 4:03:13 PM Celldex Therapeutics Q4 Loss/share $0.03 Vs. Loss $0.30 Year Ago
11/8/2016 12:07:02 PM Wedbush Is Increasing Celldex Therapeutics Inc. (CLDX) 2016 Rev. Estimate To 5.16 M From 3.19 M
11/8/2016 12:06:27 PM Wedbush Is Raising Celldex Therapeutics Inc. (CLDX) 2017 Estimate To -0.91 From -1.13
11/8/2016 12:06:02 PM Wedbush Is Raising Celldex Therapeutics Inc. (CLDX) Q4 17 Estimate To -0.20 From -0.24
11/8/2016 12:05:49 PM Wedbush Is Raising Celldex Therapeutics Inc. (CLDX) Q3 17 Estimate To -0.20 From -0.24
11/8/2016 12:05:34 PM Wedbush Is Raising Celldex Therapeutics Inc. (CLDX) Q2 17 Estimate To -0.27 From -0.35
11/8/2016 12:05:18 PM Wedbush Is Raising Celldex Therapeutics Inc. (CLDX) Q1 17 Estimate To -0.27 From -0.34
11/8/2016 12:04:57 PM Wedbush Is Raising Celldex Therapeutics Inc. (CLDX) 2016 Estimate To -1.22 From -1.34